Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Seagen Inc
(NQ:
SGEN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 13, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Seagen Inc
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Week In Review: Livzon In-Licenses GERD Therapy In $127 Million Agreement
March 18, 2023
Livzon Pharmaceutical Group entered a $127.5 million agreement for China rights to a gastroesophageal reflux disease therapy from Onconic Therapeutics. Meanwhile, Gracell Biotech announced that it had...
Via
Talk Markets
MarketBeat Week in Review – 3/13 - 3/17
March 18, 2023
The first triple witching day of 2023 is a fitting way to end a wild week. As you take some time to relax, here are some of our most popular stories this week
Via
MarketBeat
Topics
ETFs
Economy
Exposures
Interest Rates
Stock Market Diverges Amid Bank Woes, Growth Gains; First Republic, Credit Suisse, Meta In Focus: Weekly Review
March 17, 2023
A market rally is underway, but bank stocks kept tumbling.
Via
Investor's Business Daily
This Must-Buy Dividend Growth Stock Could Pay You for Life
March 16, 2023
It might not regularly beat the market, but it won't have any trouble padding your wallet.
Via
The Motley Fool
Here's How Much You Would Have Made Owning Seagen Stock In The Last 5 Years
March 15, 2023
Via
Benzinga
A Bullish Sign Appears On Seagen's Chart
March 14, 2023
Via
Benzinga
Seagen Inc. (NASDAQ: SGEN) Climbs to New 52-Week High
March 13, 2023
Via
Investor Brand Network
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
March 16, 2023
It's time for another dive into the biggest pre-market stock movers as we go over all the latest news for Thursday morning!
Via
InvestorPlace
Pfizer’s Latest Acquisition Strengthens the Case for PFE Stock
March 15, 2023
Pfizer's merger with Seagen will strengthen the company's already strong oncology portfolio and perhaps boost the case for owning PFE stock
Via
MarketBeat
Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2023
March 15, 2023
Via
Benzinga
Why Seagen Stock Is Soaring Today
March 13, 2023
Investors are cheering Pfizer's planned acquisition of Seagen.
Via
The Motley Fool
Check Out What Whales Are Doing With SGEN
March 13, 2023
Via
Benzinga
Drug Companies Raising Prices Greater Than Inflation? US Government Mulling Imposing Fines
March 15, 2023
Under Joe Biden's signature Inflation Reduction Act, drugmakers for twenty-seven drugs will be penalized for charging prices that rise faster than inflation for people with disabilities or the elderly...
Via
Benzinga
Meta Platforms To Rally Over 36%? Here Are 10 Other Analyst Forecasts For Wednesday
March 15, 2023
Credit Suisse cut the price target for Zscaler, Inc. (NASDAQ: ZS) from $275 to $165. Credit Suisse analyst Sami Badri maintained an Outperform rating. Zscaler shares fell 1.9% to $105.95 in pre-market...
Via
Benzinga
Seagen to Present New Clinical and Preclinical Data From Broad Portfolio of Targeted Cancer Therapeutics at the 2023 AACR Annual Meeting
March 14, 2023
From
Seagen Inc.
Via
Business Wire
Does This Billion-Dollar Deal Solve Pfizer's Biggest Problem?
March 14, 2023
Pfizer's planned acquisition of Seagen could be a very important move.
Via
The Motley Fool
Seagen Unusual Options Activity For March 13
March 13, 2023
Via
Benzinga
Key Inflation Meter Doesn't Show New Signs for Concern and Stocks Begin Shaking Off Instability
March 14, 2023
(Tuesday Market Open) The first of this week’s three critical data releases, February’s Consumer Price Index (CPI), was pretty much in line with expectations Tuesday, perhaps easing some concerns about...
Via
Benzinga
Is Pfizer Stock a Screaming Buy After Its $43 Billion Seagen Acquisition?
March 14, 2023
Pfizer's $43 billion Seagen acquisition is a long-term value-creation strategy.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023
March 14, 2023
Via
Benzinga
These Analysts Boost Price Targets On Seagen Following Acquisition News
March 14, 2023
Pfizer Inc (NYSE: PFE) agreed to acquire Seagen Inc (NASDAQ: SGEN) for $229 in cash per Seagen share for a total enterprise value of $43 billion. Seagen shares jumped 14.5% to close at $197.65 on...
Via
Benzinga
Jabil To Rally Around 23%? Here Are 10 Other Analyst Forecasts For Tuesday
March 14, 2023
Raymond James raised the price target for Jabil Inc. (NYSE: JBL) from $84 to $100. Raymond James analyst Melissa Fairbanks maintained a Strong Buy rating. Jabil shares fell 0.7% to close at $81.35 on...
Via
Benzinga
Did Elon Musk Just Put His Skepticism Behind And Warm Up To mRNA Tech That Powers Most COVID-19 Vaccines?
March 14, 2023
Tesla CEO Elon Musk has been a skeptic of the COVID-19 vaccines and highly critical of Dr.
Via
Benzinga
SEAGEN INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Seagen Inc. - SGEN
March 13, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Monday Merger Mania Just Made These 2 Biotech Stocks Big Winners
March 13, 2023
On a volatile market day, companies are still looking for smart combinations.
Via
The Motley Fool
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Qualtrics (Nasdaq - XM), Seagen Inc. (Nasdaq - SGEN), Provention Bio Inc. (Nasdaq - PRVB), Kimball International, Inc. (Nasdaq – KBAL)
March 13, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
SGEN Stock Alert: Pfizer Buys Seagen in GIANT $43 Billion Deal
March 13, 2023
Seagen (SGEN) stock is taking off on Monday as investors react to a $43 billion acquisition agreement with Pfizer (PFE).
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023
March 13, 2023
Via
Benzinga
Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 13, 2023
Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash.
Via
Benzinga
Illumina, Seagen And Other Big Stocks Moving Higher On Monday
March 13, 2023
U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.